Biological Psychiatry:感染多基因因素在感染与精神障碍的关系中占很小的比例

2022-07-30 影像小生 MedSci原创

感染和精神疾病共享一种适度的基因结构。感染PRSs可以预测某些精神障碍的风险;然而,这种影响是适度的。最后,记录感染在一定程度上解释了感染PRSs与精神障碍的关系。

多项研究表明,精神障碍患者在其一生中有更高的感染风险。精神障碍和炎症性疾病之间的关联表明,遗传风险变异和暴露于感染因子可能与免疫系统的异常反应有关,这给精神障碍带来更高的风险。然而,很难理清这些特征之间的因果关系。感染引起的感染因子或炎症是否会破坏神经系统发育并增加精神障碍的风险?有精神障碍的人是否会因为生活方式和行为而更容易受到感染,或者这些特征可能因其他原因而相关?了解感染和精神障碍的潜在共享遗传基础可能有助于确定这种关联的方向性,以及它受生物机制驱动的程度。最近的几项研究表明,感染在精神障碍的发展中发挥了作用;然而,基因对这种关联的贡献还没有得到充分的研究。

John R.Shorter等使用iPSYCH病例队列基因型样本(n = 65,534)和丹麦卫生保健登记数据来研究感染和精神障碍之间的遗传关联。为了验证这些关联是由于遗传多效性的假设,该研究估计了感染和精神障碍之间的遗传相关性。采用多基因风险评分(PRSs)评估感染和精神障碍的遗传多效性是否由实际感染诊断介导。研究结果发表在Biological Psychiatry。

该研究观察到精神分裂症、注意缺陷/多动障碍、重度抑郁障碍、双相情感障碍和创伤后应激障碍(rg范围在0.18到0.83之间) 与感染诊断有显著的遗传相关性,而非自闭症谱系障碍和神经性厌食症。

感染对精神疾病风险的预测能力。以误差条为95%置信区间的风险比。

记录在案的感染与七种精神疾病之间的遗传相关性。遗传相关(rg)与标准误差。PGC-SCZ,精神病学基因组学联盟-精神分裂症。

在iPSYCH病例队列中,感染的PRSs与注意缺陷/多动障碍、重度抑郁障碍和精神分裂症的风险中度增加相关(风险比= 1.04 - 1.10),但与厌食症、自闭症或双相障碍的风险无关。通过中介分析发现感染诊断仅占感染PRSs所导致精神障碍风险的一小部分(6%-14%)

中介分析流程图

感染PRSs对精神障碍诊断风险的影响,虽然统计上显著,但相对较小。这种效应可能受到直接效应的调节,可能涉及水平多效性,但也可以用未测量的第三变量效应来解释。观察到的对感染和精神障碍的显著影响很可能是由环境非遗传因素或非叠加作用遗传因素驱动的,因为可解释的方差占很小的比例。还有一种可能是,有一些遗传因素没有被PRSs捕获,从而驱动了这种联系。由于效应估计的不确定性,罕见变异不被纳入汇总统计和后期的下游分析。在临床环境中仍然可能有重要的遗传因素来帮助理解精神障碍的风险。

文献出处

Infection Polygenic Factors Account for a Small Proportion of the Relationship Between Infections and Mental Disorders.https://www.sciencedirect.com/science/article/pii/S0006322322000488

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1919474, encodeId=5d2b19194e4e0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon May 15 00:33:06 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754477, encodeId=69711e54477f8, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Mon Nov 28 02:33:06 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767919, encodeId=8ee61e6791988, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jun 14 14:33:06 CST 2023, time=2023-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792327, encodeId=a1441e9232747, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Apr 30 22:33:06 CST 2023, time=2023-04-30, status=1, ipAttribution=)]
    2023-05-15 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1919474, encodeId=5d2b19194e4e0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon May 15 00:33:06 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754477, encodeId=69711e54477f8, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Mon Nov 28 02:33:06 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767919, encodeId=8ee61e6791988, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jun 14 14:33:06 CST 2023, time=2023-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792327, encodeId=a1441e9232747, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Apr 30 22:33:06 CST 2023, time=2023-04-30, status=1, ipAttribution=)]
    2022-11-28 syscxl
  3. [GetPortalCommentsPageByObjectIdResponse(id=1919474, encodeId=5d2b19194e4e0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon May 15 00:33:06 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754477, encodeId=69711e54477f8, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Mon Nov 28 02:33:06 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767919, encodeId=8ee61e6791988, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jun 14 14:33:06 CST 2023, time=2023-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792327, encodeId=a1441e9232747, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Apr 30 22:33:06 CST 2023, time=2023-04-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1919474, encodeId=5d2b19194e4e0, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon May 15 00:33:06 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754477, encodeId=69711e54477f8, content=<a href='/topic/show?id=44e2431e1c6' target=_blank style='color:#2F92EE;'>#多基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43171, encryptionId=44e2431e1c6, topicName=多基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b34b36693912, createdName=syscxl, createdTime=Mon Nov 28 02:33:06 CST 2022, time=2022-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767919, encodeId=8ee61e6791988, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Wed Jun 14 14:33:06 CST 2023, time=2023-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1792327, encodeId=a1441e9232747, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Apr 30 22:33:06 CST 2023, time=2023-04-30, status=1, ipAttribution=)]

相关资讯

JCC: 急性重症溃疡性结肠炎患者病毒性肠道感染并不会影响预后

溃疡性结肠炎是一种病因尚不十分清楚的结肠和直肠慢性非特异性炎症性疾病,病变局限于大肠黏膜及黏膜下层。

J Clin Rheumatol:类风湿性关节炎患者使用JAK抑制剂感染风险是否会增加?

类风湿性关节炎是一种自身免疫性、慢性和炎症性疾病,全世界每1000个成年人中大约有5人受到影响。

J Antimicrob Chemother:口服康泰克唑烷治疗成人复杂皮肤和软组织感染的效果不劣于与利奈唑胺

Contezolid(康特唑烷)是一种新型的噁唑烷酮类抗菌剂,用于治疗由需氧和厌氧革兰氏阳性菌引起的感染,包括耐甲氧西林菌株。

Eur J Cardiothorac Surg:胸骨深部伤口感染局部应用庆大霉素并不会缩短患者住院时间,降低死亡率

胸骨深部伤口感染(DSWI)是心脏手术的一种破坏性并发症,会导致住院时间延长和死亡率增加。在高负压Redon引流管上进行胸骨初级封闭已被证明是一种安全和可行的治疗方法。

Nature重磅发现:孕妇会产生“超级抗体”,保护婴儿抵抗细胞内感染

这项研究打破了以往的认知,证明了母源性抗体也可以保护婴幼儿免受细胞内感染,这一发现为开创性的新疗法铺平了道路,这种疗法可以专门针对孕妇和新生儿的感染,同时这些发现也会对其他领域的抗体治疗有着深远的影响

J Clin Rheumatol:类风湿性关节炎使用不同JAK抑制剂发生严重感染的风险并无显著差异

JAKs激酶是与膜细胞因子受体相关的细胞质酪氨酸激酶,介导多种细胞因子和生长因子的信号传导,参与了多种自身免疫性疾病的发病机制。